The importance of in situ dosimetry during photodynamic therapy of Barrett's esophagus
- 1 November 2006
- journal article
- editorial
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 64 (5) , 786-788
- https://doi.org/10.1016/j.gie.2006.06.056
Abstract
No abstract availableThis publication has 23 references indexed in Scilit:
- Carpe luz—seize the light: endoprevention of esophageal adenocarcinoma when using photodynamic therapy with porfimer sodiumGastrointestinal Endoscopy, 2005
- Photodynamic therapy for Barrett's esophagus: not yet ready for the premier league of endoscopic interventionsGastrointestinal Endoscopy, 2005
- Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trialGastrointestinal Endoscopy, 2005
- Endoscopic ablation of Barrett's oesophagus: a randomized‐controlled trial of photodynamic therapy vs. argon plasma coagulationAlimentary Pharmacology & Therapeutics, 2004
- Photodynamic therapy with green light and m-tetrahydroxyphenyl chlorin for intramucosal adenocarcinoma and high-grade dysplasia in Barrett's esophagusGastrointestinal Endoscopy, 2004
- 5-Aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trialGut, 2004
- Comparison of high- vs low-dose 5-aminolevulinic acid for photodynamic therapy of Barrett?s esophagusSurgical Endoscopy, 2004
- Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trialGut, 2000
- Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IXThe Lancet, 1996
- Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagusGastrointestinal Endoscopy, 1993